LEMAITRE VASCULAR INC's ticker is LMAT and the CUSIP is 525558201. A total of 182 filers reported holding LEMAITRE VASCULAR INC in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $652,811 | +24.6% | 7,934 | +0.5% | 0.00% | – |
| Q1 2024 | $524,047 | +12.2% | 7,897 | -4.1% | 0.00% | – |
| Q4 2023 | $467,193 | +15.7% | 8,231 | +11.0% | 0.00% | – |
| Q3 2023 | $403,807 | -16.7% | 7,412 | +2.9% | 0.00% | – |
| Q2 2023 | $484,686 | -1.1% | 7,204 | -24.3% | 0.00% | – |
| Q1 2023 | $489,996 | +15.3% | 9,520 | +3.1% | 0.00% | – |
| Q4 2022 | $425,134 | -10.1% | 9,238 | -1.0% | 0.00% | – |
| Q3 2022 | $473,000 | +8.0% | 9,327 | -3.1% | 0.00% | – |
| Q2 2022 | $438,000 | +30.4% | 9,621 | +33.2% | 0.00% | – |
| Q1 2022 | $336,000 | -7.7% | 7,225 | -0.6% | 0.00% | – |
| Q4 2021 | $364,000 | -7.6% | 7,272 | -2.2% | 0.00% | – |
| Q3 2021 | $394,000 | -12.1% | 7,438 | +1.3% | 0.00% | – |
| Q2 2021 | $448,000 | +23.4% | 7,341 | -1.4% | 0.00% | – |
| Q1 2021 | $363,000 | +4.6% | 7,448 | -13.1% | 0.00% | – |
| Q4 2020 | $347,000 | +19.7% | 8,572 | -3.8% | 0.00% | – |
| Q3 2020 | $290,000 | – | 8,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 350,194 | $11,724,000 | 1.96% |
| Ranger Investment Management | 699,843 | $23,431,000 | 1.64% |
| THB ASSET MANAGEMENT | 392,100 | $13,127,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 64,550 | $2,161,000 | 1.55% |
| Conestoga Capital Advisors, LLC | 1,392,591 | $46,624,000 | 1.50% |
| Summit Creek Advisors LLC | 213,761 | $7,157,000 | 1.28% |
| Biondo Investment Advisors, LLC | 107,405 | $3,603,000 | 0.91% |
| Concorde Asset Management, LLC | 21,207 | $710,000 | 0.81% |
| Capital Impact Advisors, LLC | 51,542 | $1,739,000 | 0.64% |
| Sapphire Star Partners LP | 12,290 | $412,000 | 0.42% |